Radiation Oncology·Tampa, FL

University of South Florida Morsani/Moffitt Cancer Center

Signal lift53%73%+20 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
229–266
p10 – p90
Sample N
159
applicants this cycle
This cycle
-
no tracked aways yet
Match rate
1.3%
2 of 159 applicants
01Cohort funnelthis cycle
N = 159
Applied
159
100.0%
Invited
55
34.6%
Class size
2
1.3%
J-1 visaAdvanced
Your fitUniversity of South Florida Morsani/Moffitt Cancer Center Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at University of South Florida Morsani

Create free account

Who to contact

Training sites3 hospitals · Tampa
  • 1
    H Lee Moffitt Cancer Center and Research Institute
    Tampa, FL
    Primary
  • 2
    University of South Florida Morsani College of Medicine
    Tampa, FL
    Sponsor
  • 3
    James A Haley Veterans Hospital
    Tampa, FL
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK229 – 266
180205230255280

Level 2 CE data not available

Interview rates
US MD
53%
US DO
25%
US IMG
6%
Non-US IMG
0%
Applicant origin
In-state
100%
Out-of-state
33%
Interview prepRadiation Oncology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesRadiation Oncology · 25-26
Save this program

Add University of South Florida Morsani/Moffitt Cancer Center to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Radiation Oncology.

See how your profile compares across all programs.

Open calculator →

Program data, 2025 release. Not medical advice. © 2026 Rezumab LLC.